If TSLA keeps sliding, is the better trade buying dips or waiting for a gap-down day to trigger a fresh leg lower?
Feels like the market’s punishing TSLA for everything, but I’m not convinced it’s sustainable. If they keep improving margins and volume, does this dip actually set up a bounce? Or are we just pricing out growth again?
I’m on the sidelines because this “should go down” vibe feels premature. Guidance revisions and rate cuts could flip sentiment fast. I’d rather wait for a cleaner pullback than chase a panic move.
Momentum’s still intact: NVDA keeps crushing the sector, SPY/QQQ trend up, SOXX still underperforming. Arkk trimming now looks like a risk hedge, not a trend flip. If volume stays light, the run probably continues.
Feels like they trimmed NVDA just before Jensen stepped down, calling it risk reduction. Kinda messy timing, but not a panic sell. I’m cautiously optimistic, not convinced it’s a trend change.
Wait for a pullback or buy now?
Feels like a classic liquidity pop. If rates stay higher-for-longer and funding tightens, this kind of run usually fades fast.
Quick bounce trade or wait for a pullback?
Trend looks strong, but I’m not convinced. If we lose the 50-day or fade the 150-day, momentum flips fast. Also watching volume—without expanding OI, this could be a short-lived spike.
Feels like a classic mean reversion setup. If AAPL keeps grinding, I’m tempted to buy the dip, but is this just noise?
Everyone’s bracing for a brutal drop, but I’m skeptical. If the tech sell-off is already priced in, a fresh leg down could just be capitulation. I’d rather wait for a clean rejection before chasing.
Vol spike + 700 level = classic panic pattern.
Reading this as: AI agents promise efficiency, but they’re eating budgets that could’ve funded automation tools. If agents replace those tools, the whole automation multiple looks inflated and vulnerable.
Feeling cautious; trimming speculative AI agents and rotating some cash into proven automation exposure like PATH and automation vendors.
Does this change long-term TAM or just pricing?
For a diversified portfolio, is it better to keep MU a small speculative sleeve or wait for a clearer catalyst before adding?
Feels like the market keeps rewarding hype and punishing patience. Anyone else tired of these rollercoaster pop-and-fade cycles?
If rates stay higher for longer and funding costs rise, why should MU's multiple expand? The regulatory risk and payer uncertainty aren't priced in yet. Without a clear catalyst, this feels like a macro tailwind story, not a durable trend.
